ABOS
Acumen Pharmaceuticals, Inc.—15-min delayed · EOD close3.10 +6.16% upas of 2026-09-02mkt cap $224M
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001576885
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Operating income | −$105M | 2026-06-30 | 10-Q · 0001628280-26-056199 |
| Net income | −$105M | 2026-06-30 | 10-Q · 0001628280-26-056199 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $116M | 2026-06-30 | 10-Q · 0001628280-26-056199 |
| Current assets | $116M | 2026-06-30 | 10-Q · 0001628280-26-056199 |
| Total liabilities | $58.7M | 2026-06-30 | 10-Q · 0001628280-26-056199 |
| Current liabilities | $46.8M | 2026-06-30 | 10-Q · 0001628280-26-056199 |
| Shareholders' equity | $57.3M | 2026-06-30 | 10-Q · 0001628280-26-056199 |